AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Q BioMedIntelGenx TechnologiesHeat BiologicsMoleculin BiotechGuardion Health Sciences
SymbolOTCMKTS:QBIOOTCMKTS:IGXTNASDAQ:HTBXNASDAQ:MBRXNASDAQ:GHSI
Price Information
Current Price$1.89$0.26$0.80$1.14$0.52
52 Week RangeN/ABuyBuyBuyN/A
Beat the Market™ Rank
Overall Score0.61.91.41.20.5
Analysis Score0.03.53.53.50.0
Community Score2.62.52.92.72.5
Dividend Score0.00.00.00.00.0
Ownership Score0.03.00.00.00.0
Earnings & Valuation Score0.60.60.60.00.0
Analyst Ratings
Consensus RecommendationN/ABuyBuyBuyN/A
Consensus Price TargetN/A$1.20$5.00$2.50N/A
% Upside from Price TargetN/A362.07% upside526.96% upside119.30% upsideN/A
Trade Information
Market Cap$42.64 million$25.58 million$77.57 million$65.84 million$45.29 million
Beta2.592.280.192.4-0.08
Average Volume138,359592,44811,364,6024,649,2859,925,124
Sales & Book Value
Annual RevenueN/A$740,000.00$3.05 millionN/A$900,000.00
Price / SalesN/A38.6922.14N/A49.24
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($0.26) per shareN/A$0.39 per share$0.34 per share$0.16 per share
Price / BookN/A2.04N/A3.24
Profitability
Net Income$-10,280,000.00$-10,660,000.00$-20,020,000.00$-13,200,000.00$-10,880,000.00
EPSN/A($0.11)N/A($0.32)N/A
Trailing P/E Ratio0.00N/A0.00N/A0.00
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-1,994.13%-633.58%N/A-1,307.08%
Return on Equity (ROE)N/A-380.66%-101.83%-92.44%-123.03%
Return on Assets (ROA)-1,653.37%-80.06%-67.19%-58.87%-110.66%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.61%0.06%0.02%0.03%
Current Ratio0.19%0.73%3.91%4.26%12.46%
Quick Ratio0.19%0.68%3.91%4.26%11.80%
Ownership Information
Institutional Ownership PercentageN/AN/A8.93%7.87%1.66%
Insider Ownership PercentageN/A12.19%11.10%8.30%8.47%
Miscellaneous
Employees13830919
Shares Outstanding22.56 million110.26 million84.67 million60.40 million85.62 million
Next Earnings Date7/16/2020 (Estimated)8/13/2020 (Estimated)8/12/2020 (Estimated)8/21/2020 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.